Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:29 pm
| PEG Ratio | -0.98 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Cyient DLM Ltd operates within the Electronics – Equipment/Components industry, focusing on providing advanced technology solutions. The company’s revenue has demonstrated a robust upward trajectory, with reported sales rising from ₹721 Cr in FY 2022 to ₹832 Cr in FY 2023, and further projected at ₹1,192 Cr in FY 2024 and ₹1,345 Cr in FY 2025. The trailing twelve months (TTM) sales stood at ₹1,140 Cr. Quarterly sales figures also reflect this growth, with a notable increase from ₹170 Cr in September 2022 to ₹292 Cr in September 2023. Despite a slight dip in sales to ₹217 Cr in June 2023, the company rebounded with ₹321 Cr in December 2023, indicating a positive recovery trend. This growth trajectory positions Cyient DLM favorably against sector benchmarks, suggesting a strong market presence and operational efficiency.
Profitability and Efficiency Metrics
Profitability metrics for Cyient DLM highlight a solid operational performance, albeit with some fluctuations. The company’s operating profit margin (OPM) has varied, recording a high of 14% in September 2022 before declining to 8% in September 2023. Nevertheless, the operating profit rose from ₹84 Cr in FY 2022 to ₹88 Cr in FY 2023, with a further increase to ₹111 Cr in FY 2024. The net profit for FY 2023 was reported at ₹32 Cr, with a significant increase to ₹61 Cr projected for FY 2024 and ₹77 Cr for FY 2025. The company’s return on equity (ROE) stood at 8.23%, while the return on capital employed (ROCE) was reported at 12.3%. These figures indicate a commendable efficiency in utilizing shareholder funds, although the ROE is slightly below the typical sector range, suggesting room for improvement.
Balance Sheet Strength and Financial Ratios
Cyient DLM’s balance sheet reflects a cautious approach to leveraging, with total borrowings reported at ₹103 Cr against reserves of ₹894 Cr, indicating a strong equity position. The total liabilities stood at ₹1,490 Cr as of September 2025, with a debt-to-equity ratio of 0.25, which is favorable compared to industry norms, suggesting low financial risk. The interest coverage ratio (ICR) was reported at 4.35x, indicating a strong ability to meet interest obligations. The book value per share increased significantly from ₹37.43 in FY 2023 to ₹119.72 in FY 2025, reflecting healthy retained earnings and growth in shareholder equity. Moreover, the current ratio was recorded at 2.40, indicating robust liquidity, essential for operational flexibility. These metrics collectively demonstrate a sound financial foundation, although the price-to-book value (P/BV) ratio of 3.82x suggests that the stock may be trading at a premium relative to its book value.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cyient DLM indicates a diverse ownership structure, with promoters holding 52.12% of the shares as of June 2025. Institutional investors have a notable presence, with foreign institutional investors (FIIs) holding 2.48% and domestic institutional investors (DIIs) holding 28.16%. The public holds 17.23%, with the total number of shareholders rising to 110,618, reflecting growing retail investor interest. This distribution suggests a balanced confidence among various stakeholders, particularly as the company continues to improve its financial performance. However, the decline in promoter ownership from 66.66% in June 2023 to 52.12% in June 2025 may raise concerns about long-term commitment. This shift could impact investor sentiment, especially if perceived as a dilution of control or confidence in the company’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, Cyient DLM’s growth trajectory appears promising, bolstered by increasing revenues and a solid balance sheet. However, the company faces risks, including fluctuating profit margins and a potential decline in promoter confidence, which may impact market perception. Additionally, the electronics components sector is characterized by rapid technological advancements and competitive pressures, which could pose challenges in maintaining profitability. The company’s ability to innovate and adapt to market demands will be crucial. Conversely, strengths such as a strong liquidity position, manageable debt levels, and increasing institutional interest could provide a buffer against market volatility. In summary, while Cyient DLM is well-positioned for growth, it must navigate these risks effectively to sustain investor confidence and financial performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Cyient DLM Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Incap Ltd | 53.2 Cr. | 104 | 161/70.0 | 59.8 | 32.6 | 0.96 % | 7.61 % | 4.95 % | 10.0 |
| Gujarat Poly Electronics Ltd | 68.0 Cr. | 79.6 | 112/71.9 | 15.3 | 13.2 | 0.00 % | 12.5 % | 20.8 % | 10.0 |
| Cosmo Ferrites Ltd | 254 Cr. | 212 | 385/196 | 20.5 | 0.00 % | 0.74 % | 20.5 % | 10.0 | |
| BCC Fuba India Ltd | 246 Cr. | 161 | 219/75.1 | 58.7 | 15.1 | 0.00 % | 18.7 % | 17.4 % | 10.0 |
| PG Electroplast Ltd | 16,347 Cr. | 576 | 1,055/465 | 60.3 | 99.9 | 0.04 % | 19.4 % | 14.9 % | 1.00 |
| Industry Average | 3,815.00 Cr | 1,191.53 | 86.24 | 157.77 | 0.18% | 11.17% | 15.55% | 7.92 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 170 | 214 | 277 | 217 | 292 | 321 | 362 | 258 | 389 | 357 | 340 | 206 | 236 |
| Expenses | 146 | 194 | 245 | 197 | 268 | 292 | 324 | 238 | 358 | 328 | 283 | 181 | 208 |
| Operating Profit | 24 | 21 | 32 | 20 | 24 | 29 | 38 | 20 | 32 | 30 | 58 | 25 | 27 |
| OPM % | 14% | 10% | 12% | 9% | 8% | 9% | 11% | 8% | 8% | 8% | 17% | 12% | 12% |
| Other Income | -1 | -0 | -1 | 1 | 9 | 9 | 8 | 9 | 7 | 8 | 3 | 4 | 3 |
| Interest | 8 | 8 | 9 | 9 | 8 | 8 | 9 | 8 | 11 | 10 | 7 | 7 | 5 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 |
| Profit before tax | 10 | 7 | 17 | 7 | 20 | 25 | 31 | 14 | 21 | 21 | 47 | 15 | 18 |
| Tax % | 30% | 21% | 27% | 23% | 26% | 25% | 26% | 25% | 26% | 26% | 25% | 26% | 26% |
| Net Profit | 7 | 6 | 13 | 5 | 15 | 18 | 23 | 11 | 16 | 16 | 35 | 11 | 14 |
| EPS in Rs | 24.17 | 1.08 | 2.38 | 0.94 | 1.85 | 2.33 | 2.87 | 1.35 | 1.96 | 1.96 | 4.40 | 1.42 | 1.71 |
Last Updated: October 16, 2025, 1:43 pm
Below is a detailed analysis of the quarterly data for Cyient DLM Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 236.00 Cr.. The value appears strong and on an upward trend. It has increased from 206.00 Cr. (Jun 2025) to 236.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Sep 2025, the value is 208.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.00 Cr. (Jun 2025) to 208.00 Cr., marking an increase of 27.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Jun 2025) to 27.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 12.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 12.00%.
- For Other Income, as of Sep 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Jun 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Jun 2025) to 5.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 7.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Jun 2025) to 18.00 Cr., marking an increase of 3.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Jun 2025) to 14.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.71. The value appears strong and on an upward trend. It has increased from 1.42 (Jun 2025) to 1.71, marking an increase of 0.29.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:28 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 480 | 457 | 628 | 721 | 832 | 1,192 | 1,345 | 1,140 |
| Expenses | 462 | 443 | 582 | 636 | 744 | 1,081 | 1,206 | 1,000 |
| Operating Profit | 19 | 14 | 46 | 84 | 88 | 111 | 139 | 140 |
| OPM % | 4% | 3% | 7% | 12% | 11% | 9% | 10% | 12% |
| Other Income | 2 | 8 | 9 | 8 | 6 | 28 | 28 | 19 |
| Interest | 14 | 18 | 21 | 22 | 32 | 34 | 36 | 29 |
| Depreciation | 8 | 11 | 18 | 19 | 19 | 22 | 28 | 29 |
| Profit before tax | -1 | -7 | 16 | 51 | 43 | 82 | 103 | 101 |
| Tax % | -43% | -7% | 24% | 22% | 26% | 25% | 26% | |
| Net Profit | -1 | -7 | 12 | 40 | 32 | 61 | 77 | 75 |
| EPS in Rs | -5.78 | -49.01 | 86.39 | 291.15 | 6.00 | 7.72 | 9.67 | 9.49 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -600.00% | 271.43% | 233.33% | -20.00% | 90.62% | 26.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | 871.43% | -38.10% | -253.33% | 110.62% | -64.40% |
Cyient DLM Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
Last Updated: September 5, 2025, 2:30 am
Balance Sheet
Last Updated: October 16, 2025, 1:43 pm
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 53 | 79 | 79 | 79 |
| Reserves | 34 | 24 | 36 | 76 | 145 | 830 | 876 | 894 |
| Borrowings | 160 | 308 | 279 | 337 | 356 | 192 | 196 | 103 |
| Other Liabilities | 271 | 260 | 328 | 363 | 551 | 502 | 370 | 413 |
| Total Liabilities | 466 | 593 | 645 | 777 | 1,105 | 1,603 | 1,521 | 1,490 |
| Fixed Assets | 48 | 106 | 186 | 172 | 161 | 192 | 203 | 200 |
| CWIP | 1 | 77 | 2 | 3 | 1 | 1 | 6 | 4 |
| Investments | 0 | 0 | 0 | 0 | 90 | 66 | 156 | 153 |
| Other Assets | 417 | 410 | 457 | 601 | 853 | 1,344 | 1,156 | 1,133 |
| Total Assets | 466 | 593 | 645 | 777 | 1,105 | 1,603 | 1,521 | 1,490 |
Below is a detailed analysis of the balance sheet data for Cyient DLM Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 79.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 79.00 Cr..
- For Reserves, as of Sep 2025, the value is 894.00 Cr.. The value appears strong and on an upward trend. It has increased from 876.00 Cr. (Mar 2025) to 894.00 Cr., marking an increase of 18.00 Cr..
- For Borrowings, as of Sep 2025, the value is 103.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 196.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 93.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 413.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 370.00 Cr. (Mar 2025) to 413.00 Cr., marking an increase of 43.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,490.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,521.00 Cr. (Mar 2025) to 1,490.00 Cr., marking a decrease of 31.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 200.00 Cr.. The value appears to be declining and may need further review. It has decreased from 203.00 Cr. (Mar 2025) to 200.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 153.00 Cr.. The value appears to be declining and may need further review. It has decreased from 156.00 Cr. (Mar 2025) to 153.00 Cr., marking a decrease of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,133.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,156.00 Cr. (Mar 2025) to 1,133.00 Cr., marking a decrease of 23.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,490.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,521.00 Cr. (Mar 2025) to 1,490.00 Cr., marking a decrease of 31.00 Cr..
Notably, the Reserves (894.00 Cr.) exceed the Borrowings (103.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -141.00 | -294.00 | -233.00 | -253.00 | -268.00 | -81.00 | -57.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 91 | 44 | 132 | 77 | 71 | 69 | 81 |
| Inventory Days | 170 | 223 | 115 | 181 | 240 | 184 | 175 |
| Days Payable | 92 | 105 | 140 | 129 | 161 | 123 | 82 |
| Cash Conversion Cycle | 170 | 161 | 106 | 129 | 150 | 131 | 175 |
| Working Capital Days | 52 | -107 | -48 | -25 | -32 | 76 | 108 |
| ROCE % | 4% | 11% | 20% | 16% | 14% | 12% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Power & Infra Fund | 2,803,867 | 1.61 | 118.23 | 962,012 | 2025-10-16 07:28:50 | 191.46% |
| Nippon India Multi Cap Fund | 1,320,000 | 0.12 | 55.66 | N/A | N/A | N/A |
| Nippon India Small Cap Fund | 1,256,139 | 0.08 | 52.97 | 902,150 | 2025-10-16 07:28:50 | 39.24% |
| Aditya Birla Sun Life Pure Value Fund | 1,077,494 | 0.75 | 45.43 | N/A | N/A | N/A |
| Aditya Birla Sun Life Digital India Fund | 1,020,877 | 0.95 | 43.05 | 401,896 | 2025-10-16 07:28:50 | 154.02% |
| ICICI Prudential Technology Fund | 988,132 | 0.29 | 41.66 | N/A | N/A | N/A |
| DSP Tiger Fund | 776,839 | 0.61 | 32.76 | 774,111 | 2025-10-16 07:28:50 | 0.35% |
| Aditya Birla Sun Life Equity Hybrid 95 Fund | 717,494 | 0.41 | 30.25 | N/A | N/A | N/A |
| Nippon India Retirement Fund - Wealth Creation Scheme | 647,042 | 0.86 | 27.28 | 637,176 | 2025-10-16 07:28:50 | 1.55% |
| ICICI Prudential Multi Asset Fund | 404,620 | 0.03 | 17.06 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.58 | 8.42 | 7.75 |
| Diluted EPS (Rs.) | 8.56 | 8.39 | 7.75 |
| Cash EPS (Rs.) | 12.88 | 10.53 | 9.67 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 119.72 | 114.62 | 37.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.72 | 114.62 | 37.43 |
| Revenue From Operations / Share (Rs.) | 191.62 | 150.29 | 157.38 |
| PBDIT / Share (Rs.) | 20.59 | 17.51 | 17.80 |
| PBIT / Share (Rs.) | 16.30 | 14.69 | 14.13 |
| PBT / Share (Rs.) | 11.57 | 10.36 | 8.16 |
| Net Profit / Share (Rs.) | 8.58 | 7.72 | 6.00 |
| NP After MI And SOA / Share (Rs.) | 8.58 | 7.72 | 6.00 |
| PBDIT Margin (%) | 10.74 | 11.64 | 11.30 |
| PBIT Margin (%) | 8.50 | 9.77 | 8.97 |
| PBT Margin (%) | 6.03 | 6.89 | 5.18 |
| Net Profit Margin (%) | 4.47 | 5.13 | 3.81 |
| NP After MI And SOA Margin (%) | 4.47 | 5.13 | 3.81 |
| Return on Networth / Equity (%) | 7.17 | 6.73 | 16.03 |
| Return on Capital Employeed (%) | 11.14 | 10.95 | 20.75 |
| Return On Assets (%) | 4.01 | 3.81 | 2.87 |
| Long Term Debt / Equity (X) | 0.15 | 0.08 | 0.50 |
| Total Debt / Equity (X) | 0.25 | 0.14 | 1.59 |
| Asset Turnover Ratio (%) | 0.92 | 0.88 | 0.00 |
| Current Ratio (X) | 2.40 | 2.46 | 1.13 |
| Quick Ratio (X) | 1.33 | 1.60 | 0.55 |
| Inventory Turnover Ratio (X) | 2.10 | 2.13 | 0.00 |
| Interest Coverage Ratio (X) | 4.35 | 4.04 | 2.99 |
| Interest Coverage Ratio (Post Tax) (X) | 2.81 | 2.78 | 2.01 |
| Enterprise Value (Cr.) | 3581.45 | 5308.59 | 0.00 |
| EV / Net Operating Revenue (X) | 2.36 | 4.45 | 0.00 |
| EV / EBITDA (X) | 21.93 | 38.24 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 2.39 | 4.79 | 0.00 |
| Price / BV (X) | 3.82 | 6.28 | 0.00 |
| Price / Net Operating Revenue (X) | 2.39 | 4.79 | 0.00 |
| EarningsYield | 0.01 | 0.01 | 0.00 |
After reviewing the key financial ratios for Cyient DLM Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.58. This value is within the healthy range. It has increased from 8.42 (Mar 24) to 8.58, marking an increase of 0.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.56. This value is within the healthy range. It has increased from 8.39 (Mar 24) to 8.56, marking an increase of 0.17.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.88. This value is within the healthy range. It has increased from 10.53 (Mar 24) to 12.88, marking an increase of 2.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.72. It has increased from 114.62 (Mar 24) to 119.72, marking an increase of 5.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.72. It has increased from 114.62 (Mar 24) to 119.72, marking an increase of 5.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 191.62. It has increased from 150.29 (Mar 24) to 191.62, marking an increase of 41.33.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 20.59. This value is within the healthy range. It has increased from 17.51 (Mar 24) to 20.59, marking an increase of 3.08.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.30. This value is within the healthy range. It has increased from 14.69 (Mar 24) to 16.30, marking an increase of 1.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.57. This value is within the healthy range. It has increased from 10.36 (Mar 24) to 11.57, marking an increase of 1.21.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.58. This value is within the healthy range. It has increased from 7.72 (Mar 24) to 8.58, marking an increase of 0.86.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.58. This value is within the healthy range. It has increased from 7.72 (Mar 24) to 8.58, marking an increase of 0.86.
- For PBDIT Margin (%), as of Mar 25, the value is 10.74. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 10.74, marking a decrease of 0.90.
- For PBIT Margin (%), as of Mar 25, the value is 8.50. This value is below the healthy minimum of 10. It has decreased from 9.77 (Mar 24) to 8.50, marking a decrease of 1.27.
- For PBT Margin (%), as of Mar 25, the value is 6.03. This value is below the healthy minimum of 10. It has decreased from 6.89 (Mar 24) to 6.03, marking a decrease of 0.86.
- For Net Profit Margin (%), as of Mar 25, the value is 4.47. This value is below the healthy minimum of 5. It has decreased from 5.13 (Mar 24) to 4.47, marking a decrease of 0.66.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.47. This value is below the healthy minimum of 8. It has decreased from 5.13 (Mar 24) to 4.47, marking a decrease of 0.66.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.17. This value is below the healthy minimum of 15. It has increased from 6.73 (Mar 24) to 7.17, marking an increase of 0.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.14. This value is within the healthy range. It has increased from 10.95 (Mar 24) to 11.14, marking an increase of 0.19.
- For Return On Assets (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 5. It has increased from 3.81 (Mar 24) to 4.01, marking an increase of 0.20.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.08 (Mar 24) to 0.15, marking an increase of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 0.25, marking an increase of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.92. It has increased from 0.88 (Mar 24) to 0.92, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 2.40. This value is within the healthy range. It has decreased from 2.46 (Mar 24) to 2.40, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.33, marking a decrease of 0.27.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.10. This value is below the healthy minimum of 4. It has decreased from 2.13 (Mar 24) to 2.10, marking a decrease of 0.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.35. This value is within the healthy range. It has increased from 4.04 (Mar 24) to 4.35, marking an increase of 0.31.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.81. This value is below the healthy minimum of 3. It has increased from 2.78 (Mar 24) to 2.81, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,581.45. It has decreased from 5,308.59 (Mar 24) to 3,581.45, marking a decrease of 1,727.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.36. This value is within the healthy range. It has decreased from 4.45 (Mar 24) to 2.36, marking a decrease of 2.09.
- For EV / EBITDA (X), as of Mar 25, the value is 21.93. This value exceeds the healthy maximum of 15. It has decreased from 38.24 (Mar 24) to 21.93, marking a decrease of 16.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 4.79 (Mar 24) to 2.39, marking a decrease of 2.40.
- For Price / BV (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has decreased from 6.28 (Mar 24) to 3.82, marking a decrease of 2.46.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 4.79 (Mar 24) to 2.39, marking a decrease of 2.40.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cyient DLM Ltd:
- Net Profit Margin: 4.47%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.14% (Industry Average ROCE: 11.17%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.17% (Industry Average ROE: 15.55%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.81
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 48.4 (Industry average Stock P/E: 86.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.47%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Electronics - Equipment/Components | Plot No. 5G, Survey No. 99/1, Hyderabad Telangana 500108 | company.secretary@cyientdlm.com http://www.cyientdlm.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Krishna Bodanapu | Non Executive Chairman |
| Mr. Rajendra Velagapudi | Managing Director |
| Mr. B V R Mohan Reddy | Non Executive Director |
| Ms. Vanitha Datla | Independent Director |
| Mr. Jehangir Ardeshir | Independent Director |
| Mr. Muralidhar Yadama | Independent Director |
| Dr. Ajay Kumar | Independent Director |
| Mr. Madan Pillutla | Independent Director |
FAQ
What is the intrinsic value of Cyient DLM Ltd?
Cyient DLM Ltd's intrinsic value (as of 03 November 2025) is 399.80 which is 12.90% lower the current market price of 459.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,644 Cr. market cap, FY2025-2026 high/low of 744/350, reserves of ₹894 Cr, and liabilities of 1,490 Cr.
What is the Market Cap of Cyient DLM Ltd?
The Market Cap of Cyient DLM Ltd is 3,644 Cr..
What is the current Stock Price of Cyient DLM Ltd as on 03 November 2025?
The current stock price of Cyient DLM Ltd as on 03 November 2025 is 459.
What is the High / Low of Cyient DLM Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cyient DLM Ltd stocks is 744/350.
What is the Stock P/E of Cyient DLM Ltd?
The Stock P/E of Cyient DLM Ltd is 48.4.
What is the Book Value of Cyient DLM Ltd?
The Book Value of Cyient DLM Ltd is 123.
What is the Dividend Yield of Cyient DLM Ltd?
The Dividend Yield of Cyient DLM Ltd is 0.00 %.
What is the ROCE of Cyient DLM Ltd?
The ROCE of Cyient DLM Ltd is 12.3 %.
What is the ROE of Cyient DLM Ltd?
The ROE of Cyient DLM Ltd is 8.23 %.
What is the Face Value of Cyient DLM Ltd?
The Face Value of Cyient DLM Ltd is 10.0.